The breast cancer CSCs have the BMI1 protein placed around stalled replication forks to engage RAD51 to activate the homologous recombination machinery to confirm that the BMI1/RAD51 axis is necessary to prevent cisplatin-induced cisplatin DNA damage [179]. This evidence concerns the gene RAD51 and breast cancer.